ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC30618-1mg |
|
314-50-1 |
Orotidine
|
0 | C10H12N2O8 | |
GC30617-5mg |
|
25597-07-3 |
Tetradecanoylcarnitine
|
0 | C21H41NO4 | |
GC30616-100mg |
|
300-85-6 |
3-Hydroxybutyric acid
|
0 | C4H8O3 | |
GC30615-100mg |
|
583-08-4 |
Nicotinuric acid
|
0 | C8H8N2O3 | |
GC30614-1g |
|
— |
α-Cyclodextrin
|
0 | — | |
GC30614-10mM(1mLinDMSO) |
|
— |
α-Cyclodextrin
|
0 | — | |
GC30613-50mg |
|
5720-26-3 |
5-Hydroxydopamine hydrochloride
|
0 | C8H12ClNO3 | |
GC30612-5mg |
|
18294-85-4 |
2-Hydroxyadipic acid
|
0 | C6H10O5 | |
GC30611-5mg |
|
68422-00-4 |
Timosaponin A1
|
0 | C33H54O8 | |
GC30611-10mM(1mLinDMSO) |
|
68422-00-4 |
Timosaponin A1
|
0 | C33H54O8 | |
GC30610-20mg |
|
107889-32-7 |
LY 178002
|
0 | C18H25NO2S | |
GC30610-10mg |
|
107889-32-7 |
LY 178002
|
0 | C18H25NO2S | |
GC30610-5mg |
|
107889-32-7 |
LY 178002
|
0 | C18H25NO2S | |
GC30610-1mg |
|
107889-32-7 |
LY 178002
|
0 | C18H25NO2S | |
GC30609-20mg |
|
635725-16-5 |
p38 MAPK-IN-2
|
0 | C20H19ClFN5O2 | |
GC30609-10mg |
|
635725-16-5 |
p38 MAPK-IN-2
|
0 | C20H19ClFN5O2 | |
GC30609-5mg |
|
635725-16-5 |
p38 MAPK-IN-2
|
0 | C20H19ClFN5O2 | |
GC30609-1mg |
|
635725-16-5 |
p38 MAPK-IN-2
|
0 | C20H19ClFN5O2 | |
GC30608-20mg |
|
82101-17-5 |
Ipsalazide
|
0 | C16H11N3Na2O6 | |
GC30608-10mg |
|
82101-17-5 |
Ipsalazide
|
0 | C16H11N3Na2O6 | |